Inozyme Pharma(INZY)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INZY Inozyme Pharma

未开盘 05-02 16:00:00 EDT

1.62

+0.41

+33.88%

盘后1.55

-0.07-4.31%

19:58 EDT

最高1.85	最低1.18	成交量810.67万
今开1.21	昨收1.21	日振幅55.37%
总市值1.04亿	流通市值5,806万	总股本6,424万
成交额1,318万	换手率22.62%	流通股本3,584万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INZY","market":"US","secType":"STK","nameCN":"Inozyme Pharma","latestPrice":1.62,"timestamp":1746216000000,"preClose":1.21,"halted":0,"volume":8106743,"hourTrading":{"tag":"盘后","latestPrice":1.5501,"preClose":1.62,"latestTime":"19:58 EDT","volume":147027,"amount":236758.8704,"timestamp":1746230290863},"delay":0,"floatShares":35838418,"shares":64240198,"eps":-1.62428,"marketStatus":"未开盘","change":0.41,"latestTime":"05-02 16:00:00 EDT","open":1.21,"high":1.85,"low":1.18,"amount":13180323.786321001,"amplitude":0.553719,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.62428,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"listingDate":1595563200000,"exchange":"NASDAQ","adjPreClose":1.21,"postHourTrading":{"tag":"盘后","latestPrice":1.5501,"preClose":1.62,"latestTime":"19:58 EDT","volume":147027,"amount":236758.8704,"timestamp":1746230290863},"volumeRatio":18.603527873223737,"impliedVol":1.9956,"impliedVolPercentile":0.772},"requestUrl":"/m/hq/s/INZY","defaultTab":"news","newsList":[{"id":"2532212844","title":"Inozyme Pharma, Inc.盘中异动 早盘股价大涨5.79%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532212844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532212844?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:37","pubTimestamp":1746193046,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时37分，Inozyme Pharma, Inc.股票出现异动，股价急速拉升5.79%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.69%。其相关个股中，Polyrizon Ltd.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Adaptive Biotechnologies Corporation涨幅较大，Pmgc Holdings Inc.、Polyrizon Ltd.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为219.15%、168.94%、63.78%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Polyrizon Ltd.、Adaptive Biotechnologies Corporation，振幅分别为67.34%、38.99%、21.71%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma Inc 是一家临床阶段的生物制药公司，开发用于治疗影响骨骼健康和血管功能的疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050221372794eac33b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050221372794eac33b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2531768257","title":"Inozyme Pharma, Inc.盘中异动 股价大涨5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531768257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531768257?lang=zh_cn&edition=full","pubTime":"2025-04-29 23:39","pubTimestamp":1745941178,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日23时39分，Inozyme Pharma, Inc.股票出现波动，股价大幅上涨5.75%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Kala Bio, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Ibio, Inc.较为活跃，换手率分别为149.05%、145.31%、44.47%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Spruce Biosciences, Inc.，振幅分别为134.52%、50.68%、41.73%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma Inc 是一家临床阶段的生物制药公司，开发用于治疗影响骨骼健康和血管功能的疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429233938a6cd8a4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429233938a6cd8a4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2530231801","title":"Inozyme Pharma, Inc.盘中异动 大幅下挫5.24%报0.933美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530231801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530231801?lang=zh_cn&edition=full","pubTime":"2025-04-28 23:28","pubTimestamp":1745854136,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日23时28分，Inozyme Pharma, Inc.股票出现异动，股价快速下跌5.24%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Cg Oncology, Inc.、Ibio, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Springworks Therapeutics, Inc.较为活跃，换手率分别为2427.14%、459.48%、82.93%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Ibio, Inc.，振幅分别为53.50%、36.31%、30.46%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma Inc 是一家临床阶段的生物制药公司，开发用于治疗影响骨骼健康和血管功能的疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504282328569748b02b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504282328569748b02b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2529659634","title":"Inozyme Pharma, Inc.盘中异动 早盘股价大跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529659634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529659634?lang=zh_cn&edition=full","pubTime":"2025-04-23 23:23","pubTimestamp":1745421839,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日23时23分，Inozyme Pharma, Inc.股票出现波动，股价快速跳水5.53%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423232359a46414c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423232359a46414c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2529861245","title":"Inozyme Pharma, Inc.盘中异动 股价大涨6.18%报1.040美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529861245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529861245?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:46","pubTimestamp":1745329599,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时46分，Inozyme Pharma, Inc.股票出现波动，股价急速拉升6.18%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221463994de36e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221463994de36e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2528078744","title":"Inozyme Pharma, Inc.盘中异动 急速下跌5.23%报0.912美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528078744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528078744?lang=zh_cn&edition=full","pubTime":"2025-04-17 23:00","pubTimestamp":1744902031,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日23时00分，Inozyme Pharma, Inc.股票出现异动，股价大幅下跌5.23%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、Portage Biotech Inc.涨幅较大，Channel Therapeutics Corporation、Transcode Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为574.92%、198.64%、167.74%，振幅较大的相关个股有Channel Therapeutics Corporation、Processa Pharmaceuticals, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为45.42%、43.27%、40.38%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417230031aa2c7340&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417230031aa2c7340&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2527114229","title":"Inozyme Pharma, Inc.盘中异动 大幅拉升5.35%报0.934美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527114229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527114229?lang=zh_cn&edition=full","pubTime":"2025-04-15 02:21","pubTimestamp":1744654907,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日02时21分，Inozyme Pharma, Inc.股票出现波动，股价快速拉升5.35%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为2.34%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150221479737ae99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150221479737ae99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2518227448","title":"Inozyme Pharma, Inc.盘中异动 早盘大幅跳水6.09%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227448?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:58","pubTimestamp":1741615115,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时58分，Inozyme Pharma, Inc.股票出现异动，股价快速下跌6.09%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2993.27%、652.77%、253.88%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021583598a2a404&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021583598a2a404&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"1167860545","title":"Inozyme Pharma 2024财年GAAP每股收益$(1.62)，低于预期$(1.60)；公司优先支持计划为INZ-701申请生物制剂许可证，并宣布裁员25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167860545","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167860545?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:38","pubTimestamp":1741610306,"startTime":"0","endTime":"0","summary":"公司优先支持计划为INZ-701申请生物制剂许可证，并宣布裁员25%。以上内容来自Benzinga Earnings专栏，原文如下：$Inozyme Pharma$ FY 2024 GAAP EPS $ Misses $ Estimate; Co. Prioritizes Activities To Support Planned Biologics License Application Filing For INZ-701 In ENPP1 Deficiency, Announces 25% Workforce Reduction","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Inozyme Pharma 2024财年GAAP每股收益$(1.62)，低于预期$(1.60)；公司优先支持计划为INZ-701申请生物制剂许可证，并宣布裁员25%","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INZY"],"gpt_icon":0},{"id":"2517607558","title":"Inozyme Pharma, Inc.盘中异动 下午盘大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517607558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517607558?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:10","pubTimestamp":1741111848,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时10分，Inozyme Pharma, Inc.股票出现异动，股价大幅拉升5.05%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305021049abe82cb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305021049abe82cb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2516634256","title":"Inozyme Pharma, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634256?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012308,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Inozyme Pharma, Inc.股票出现异动，股价快速上涨5.13%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.23%、24.98%、22.45%，振幅较大的相关个股有Entero Therapeutics Inc.、Cibus, Inc.、Galmed Pharmaceuticals Ltd.，振幅分别为16.84%、9.55%、9.35%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223149a25d3fbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223149a25d3fbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2514138271","title":"Inozyme Pharma, Inc.盘中异动 股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514138271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514138271?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:16","pubTimestamp":1740672997,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时16分，Inozyme Pharma, Inc.股票出现波动，股价急速上涨5.37%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280016379632c763&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280016379632c763&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2511691848","title":"Inozyme Pharma, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511691848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511691848?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:50","pubTimestamp":1739544619,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时50分，Inozyme Pharma, Inc.股票出现异动，股价快速上涨5.19%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1908.46%、496.94%、427.45%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422501998858e54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422501998858e54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2511218275","title":"Inozyme Pharma, Inc.盘中异动 快速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511218275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511218275?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:10","pubTimestamp":1739459417,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时10分，Inozyme Pharma, Inc.股票出现异动，股价快速下跌5.19%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132310189621c4a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132310189621c4a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2510339322","title":"Inozyme Pharma, Inc.盘中异动 早盘大幅跳水5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510339322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510339322?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:04","pubTimestamp":1739289886,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时04分，Inozyme Pharma, Inc.股票出现异动，股价快速跳水5.36%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.60%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2765.33%、1207.66%、397.40%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、40.87%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212000446961f58f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212000446961f58f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2510897019","title":"Inozyme Pharma, Inc.盘中异动 股价大跌5.52%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510897019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510897019?lang=zh_cn&edition=full","pubTime":"2025-02-11 04:49","pubTimestamp":1739220567,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日04时49分，Inozyme Pharma, Inc.股票出现异动，股价急速跳水5.52%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.94%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110449289880bf34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110449289880bf34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2509872822","title":"Inozyme Pharma, Inc.盘中异动 大幅上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509872822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509872822?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:54","pubTimestamp":1738767294,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时54分，Inozyme Pharma, Inc.股票出现异动，股价急速拉升5.15%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.75%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205225454a23a8009&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205225454a23a8009&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2508918457","title":"Inozyme Pharma, Inc.盘中异动 早盘急速拉升5.07%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508918457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508918457?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:30","pubTimestamp":1738679456,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时30分，Inozyme Pharma, Inc.股票出现波动，股价快速上涨5.07%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Azitra Inc、Evaxion Biotech As、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为830.17%、669.38%、184.80%，振幅较大的相关个股有Azitra Inc、Septerna, Inc.、Inozyme Pharma, Inc.，振幅分别为13.82%、7.01%、5.80%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223057987a4a31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223057987a4a31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INZY"],"gpt_icon":0},{"id":"2508514101","title":"Inozyme Pharma, Inc.盘中异动 大幅跳水5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508514101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508514101?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:03","pubTimestamp":1738595011,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时03分，Inozyme Pharma, Inc.股票出现波动，股价急速下挫5.90%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032303319617016e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032303319617016e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0},{"id":"2507965079","title":"Inozyme Pharma, Inc.盘中异动 早盘股价大涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507965079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507965079?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:34","pubTimestamp":1738334090,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时34分，Inozyme Pharma, Inc.股票出现波动，股价大幅拉升5.48%。Inozyme Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Inozyme Pharma, Inc.公司简介：Inozyme Pharma 是一家临床阶段的罕见病生物制药公司，致力于开发用于治疗影响血管、软组织和骨骼疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223450abbe3c40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223450abbe3c40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INZY","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inozyme.com","stockEarnings":[{"period":"1week","weight":0.646},{"period":"1month","weight":0.7487},{"period":"3month","weight":0.125},{"period":"6month","weight":-0.6284},{"period":"1year","weight":-0.6516},{"period":"ytd","weight":-0.4152}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inozyme Pharma, Inc.根据特拉华州法律成立于2015年9月。该公司是一家罕见的疾病生物制药公司，致力于开发新颖的疗法来治疗影响血管，软组织和骨骼的异常矿化疾病。通过对矿化所涉及的生物途径的深入了解，该公司致力于开发治疗剂以解决这些使人衰弱的疾病的根本原因。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.22291},{"month":2,"riseRate":0.4,"avgChangeRate":-0.005308},{"month":3,"riseRate":0.4,"avgChangeRate":0.137262},{"month":4,"riseRate":0.2,"avgChangeRate":-0.059967},{"month":5,"riseRate":0.6,"avgChangeRate":0.081648},{"month":6,"riseRate":0.5,"avgChangeRate":0.047361},{"month":7,"riseRate":0.25,"avgChangeRate":-0.006548},{"month":8,"riseRate":0.2,"avgChangeRate":0.036393},{"month":9,"riseRate":0,"avgChangeRate":-0.135388},{"month":10,"riseRate":0,"avgChangeRate":-0.227258},{"month":11,"riseRate":0.4,"avgChangeRate":-0.05305},{"month":12,"riseRate":0.4,"avgChangeRate":-0.09901}],"exchange":"NASDAQ","name":"Inozyme Pharma","nameEN":"Inozyme Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inozyme Pharma(INZY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inozyme Pharma(INZY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inozyme Pharma,INZY,Inozyme Pharma股票,Inozyme Pharma股票老虎,Inozyme Pharma股票老虎国际,Inozyme Pharma行情,Inozyme Pharma股票行情,Inozyme Pharma股价,Inozyme Pharma股市,Inozyme Pharma股票价格,Inozyme Pharma股票交易,Inozyme Pharma股票购买,Inozyme Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inozyme Pharma(INZY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inozyme Pharma(INZY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况